| Communication Strategies to Introduce Psychology Services (NCT03035448) | M.D. Anderson Cancer Center | 2017-02-13 |
| Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors (NCT03035409) | M.D. Anderson Cancer Center | 2017-02-08 |
| Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR) (NCT02960555) | M.D. Anderson Cancer Center | 2017-02-08 |
| Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome (NCT02846623) | M.D. Anderson Cancer Center | 2017-01-31 |
| Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy (NCT02971748) | M.D. Anderson Cancer Center | 2017-01-26 |
| Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families (NCT04125914) | M.D. Anderson Cancer Center | 2017-01-26 |
| Comprehensive Nutritional Geriatric Assessments in Identifying Malnutrition in Older Cancer Participants (NCT03035604) | M.D. Anderson Cancer Center | 2017-01-24 |
| Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy (NCT02945579) | M.D. Anderson Cancer Center | 2017-01-20 |
| Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (NCT03058926) | M.D. Anderson Cancer Center | 2017-01-19 |
| Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases (NCT03028337) | M.D. Anderson Cancer Center | 2017-01-18 |
| Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT02960646) | M.D. Anderson Cancer Center | 2017-01-18 |
| Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer (NCT03028311) | M.D. Anderson Cancer Center | 2017-01-09 |
| Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer (NCT03010150) | M.D. Anderson Cancer Center | 2016-12-29 |
| Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle (NCT03004586) | M.D. Anderson Cancer Center | 2016-12-16 |
| Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer (NCT02696993) | M.D. Anderson Cancer Center | 2016-12-16 |
| Pembrolizumab (MK-3475) in Hepatocellular Carcinoma (NCT02940496) | M.D. Anderson Cancer Center | 2016-12-09 |
| Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma (NCT02910700) | M.D. Anderson Cancer Center | 2016-12-09 |
| Obinutuzumab and Lenalidomide in Treating Patients With Previously Untreated Stage II-IV Grade 1-3a Follicular Lymphoma (NCT02871219) | M.D. Anderson Cancer Center | 2016-12-06 |
| Lenvatinib and Capecitabine in Patients With Advanced Malignancies (NCT02915172) | M.D. Anderson Cancer Center | 2016-12-01 |
| Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer (NCT02907099) | M.D. Anderson Cancer Center | 2016-12-01 |
| Adoptive Therapy Using Antigen-Specific CD4 T-Cells (NCT02210104) | M.D. Anderson Cancer Center | 2016-12-01 |
| Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC) (NCT02950038) | M.D. Anderson Cancer Center | 2016-12-01 |
| CBCT in Guiding Bronchoscopy in Patients With Lung Lesions (NCT02978170) | M.D. Anderson Cancer Center | 2016-11-28 |
| Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery (NCT02884648) | M.D. Anderson Cancer Center | 2016-11-15 |
| Olaparib in Treating Patients With Stage IV Pancreatic Cancer (NCT02677038) | M.D. Anderson Cancer Center | 2016-11-11 |
| Expectations Regarding Mobility and Self-Care (NCT02911064) | M.D. Anderson Cancer Center | 2016-11-10 |
| Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version) (NCT02515383) | M.D. Anderson Cancer Center | 2016-11-09 |
| DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer (NCT02744053) | M.D. Anderson Cancer Center | 2016-11-07 |
| Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC (NCT02593175) | M.D. Anderson Cancer Center | 2016-11-03 |
| Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care Visit (NCT02957565) | M.D. Anderson Cancer Center | 2016-11-03 |
| Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia (NCT02877303) | M.D. Anderson Cancer Center | 2016-11-01 |
| Randomized AmnioFix Study During Radical Prostatectomy (NCT02645591) | M.D. Anderson Cancer Center | 2016-11-01 |
| FDG PET Imaging in Diagnosing Patients With Glioblastoma (NCT02885272) | M.D. Anderson Cancer Center | 2016-10-28 |
| Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure (NCT02906696) | M.D. Anderson Cancer Center | 2016-10-28 |
| Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing Chemotherapy (NCT03964896) | M.D. Anderson Cancer Center | 2016-10-17 |
| Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers (NCT02774759) | M.D. Anderson Cancer Center | 2016-10-17 |
| Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy (NCT02732015) | M.D. Anderson Cancer Center | 2016-10-12 |
| High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients (NCT02932332) | M.D. Anderson Cancer Center | 2016-10-11 |
| Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer (NCT02876107) | M.D. Anderson Cancer Center | 2016-10-06 |
| Early Metabolic Support as a Potential Solution to Multi-Organ Dysfunction Syndrome (MODS) During Severe Sepsis (NCT02885688) | M.D. Anderson Cancer Center | 2016-10-01 |
| High-Intensity Interval Training for Women at Heightened Risk for Breast Cancer (NCT02923401) | M.D. Anderson Cancer Center | 2016-09-30 |
| Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis (NCT02784496) | M.D. Anderson Cancer Center | 2016-09-29 |
| Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02882321) | M.D. Anderson Cancer Center | 2016-09-29 |
| Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery (NCT02738606) | M.D. Anderson Cancer Center | 2016-09-23 |
| Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer (NCT02689427) | M.D. Anderson Cancer Center | 2016-09-22 |
| Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment (NCT02754752) | M.D. Anderson Cancer Center | 2016-09-13 |
| Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML) (NCT02829840) | M.D. Anderson Cancer Center | 2016-09-01 |
| Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer (NCT02891447) | M.D. Anderson Cancer Center | 2016-09-01 |
| Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies (NCT02812056) | M.D. Anderson Cancer Center | 2016-09-01 |
| Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway (NCT02740114) | M.D. Anderson Cancer Center | 2016-08-31 |
| Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Relapsed and/or Refractory Multiple Myeloma (NCT02579824) | M.D. Anderson Cancer Center | 2016-08-30 |
| Supervised Exercise in Improving Physical Fitness Before Surgery in Patients With Resectable Bone Cancer (NCT02893397) | M.D. Anderson Cancer Center | 2016-08-30 |
| Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery (NCT02754856) | M.D. Anderson Cancer Center | 2016-08-29 |
| Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord (NCT02713269) | M.D. Anderson Cancer Center | 2016-08-29 |
| Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer (NCT02684227) | M.D. Anderson Cancer Center | 2016-08-24 |
| Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes (NCT02815995) | M.D. Anderson Cancer Center | 2016-08-16 |
| Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic (NCT02721732) | M.D. Anderson Cancer Center | 2016-08-15 |
| Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases (NCT02798029) | M.D. Anderson Cancer Center | 2016-08-08 |
| Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors (NCT02478320) | M.D. Anderson Cancer Center | 2016-08-05 |
| Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant (NCT02861417) | M.D. Anderson Cancer Center | 2016-08-05 |
| Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation (NCT02697227) | M.D. Anderson Cancer Center | 2016-08-05 |
| Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery (NCT02658812) | M.D. Anderson Cancer Center | 2016-08-01 |
| Effects of a Group Residential Retreat on Cancer Outcomes (NCT02429544) | M.D. Anderson Cancer Center | 2016-08-01 |
| Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia (NCT02807883) | M.D. Anderson Cancer Center | 2016-08-01 |
| Phase II Study of Pazopanib and Topotecan in Cervical Cancer (NCT02348398) | M.D. Anderson Cancer Center | 2016-08-01 |
| The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) Trial (NCT02843425) | M.D. Anderson Cancer Center | 2016-07-25 |
| Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors (NCT02754544) | M.D. Anderson Cancer Center | 2016-07-22 |
| Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation Therapy (NCT02698254) | M.D. Anderson Cancer Center | 2016-07-20 |
| Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma (NCT02603887) | M.D. Anderson Cancer Center | 2016-07-20 |
| Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia (NCT02756897) | M.D. Anderson Cancer Center | 2016-07-07 |
| Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur) (NCT02726997) | M.D. Anderson Cancer Center | 2016-07-06 |
| A Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL) (NCT02801578) | M.D. Anderson Cancer Center | 2016-07-06 |
| Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT02520154) | M.D. Anderson Cancer Center | 2016-07-05 |
| Non Invasive Oral Cancer Screening Among HIV Infected Individuals (NCT02823847) | M.D. Anderson Cancer Center | 2016-06-30 |
| Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant (NCT02684162) | M.D. Anderson Cancer Center | 2016-06-22 |
| Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype (NCT02589145) | M.D. Anderson Cancer Center | 2016-06-22 |
| Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer (NCT02321501) | M.D. Anderson Cancer Center | 2016-06-22 |
| Tu Salud Si Cuenta Intervention in Increasing Physical Activity and Healthy Eating Among Latino Families (NCT03199365) | M.D. Anderson Cancer Center | 2016-06-10 |
| Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies (NCT05136807) | M.D. Anderson Cancer Center | 2016-06-07 |
| Your Health Matters! (Tu Salud ¡Si Cuenta!): Promoting Healthy Lifestyles in Latino Families (NCT03199209) | M.D. Anderson Cancer Center | 2016-06-06 |
| Ibrutinib Post Stem Cell Transplantation (SCT) in Double-Hit B-Cell Lymphoma (NCT02272686) | M.D. Anderson Cancer Center | 2016-06-03 |
| Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma (NCT02701673) | M.D. Anderson Cancer Center | 2016-06-01 |
| Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis (NCT02740127) | M.D. Anderson Cancer Center | 2016-06-01 |
| Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma (NCT02661282) | M.D. Anderson Cancer Center | 2016-06-01 |
| Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy (NCT02710253) | M.D. Anderson Cancer Center | 2016-05-25 |
| Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders (NCT02790853) | M.D. Anderson Cancer Center | 2016-05-25 |
| Personalized NK Cell Therapy in CBT (NCT02727803) | M.D. Anderson Cancer Center | 2016-05-19 |
| Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer (NCT02703623) | M.D. Anderson Cancer Center | 2016-05-18 |
| Mesenchymal Stem Cells (MSC) for Ovarian Cancer (NCT02530047) | M.D. Anderson Cancer Center | 2016-05-16 |
| Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI) (NCT02613728) | M.D. Anderson Cancer Center | 2016-05-13 |
| Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies (NCT02668770) | M.D. Anderson Cancer Center | 2016-05-11 |
| Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer (NCT02600949) | M.D. Anderson Cancer Center | 2016-05-11 |
| LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02652871) | M.D. Anderson Cancer Center | 2016-05-09 |
| Prexasertib (LY2606368), Cytarabine, and Fludarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT02649764) | M.D. Anderson Cancer Center | 2016-05-04 |
| Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations (NCT02760849) | M.D. Anderson Cancer Center | 2016-05-02 |
| Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis (NCT02623959) | M.D. Anderson Cancer Center | 2016-04-27 |
| Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer (NCT03085043) | M.D. Anderson Cancer Center | 2016-04-20 |
| Telemonitoring After Surgery to Preserve Limb Function in Optimizing Mobility in Cancer Survivors With Skeletal Metastases (NCT02715856) | M.D. Anderson Cancer Center | 2016-04-13 |
| Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma (NCT02532257) | M.D. Anderson Cancer Center | 2016-04-11 |
| Effects of Social Networking on Chronic Disease Management in Arthritis (NCT02717403) | M.D. Anderson Cancer Center | 2016-04-07 |